Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

被引:523
作者
Simoni, Jane M.
Kurth, Ann E.
Pearson, Cynthia R.
Pantalone, David W.
Merrill, Joseph O.
Frick, Pamela A.
机构
[1] Univ Washington, Dept Psychol, Seattle, WA 98195 USA
[2] Univ Washington, Sch Nursing CFAR, Seattle, WA 98195 USA
[3] Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Med, Seattle, WA 98195 USA
[5] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
关键词
HIV/AIDS; antiretroviral; medication adherence; self-report; viral load;
D O I
10.1007/s10461-006-9078-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A review of 77 studies employing self-report measures of antiretroviral adherence published 1/1996 through 8/2004 revealed great variety in adherence assessment item content, format, and response options. Recall periods ranged from 2 to 365 days (mode = 7 days). The most common cutoff for optimal adherence was 100% (21/48 studies, or 44%). In 27 of 34 recall periods (79%), self-reported adherence was associated with adherence as assessed with other indirect measures. Data from 57 of 67 recall periods (84%) indicated self-reported adherence was significantly associated with HIV-1 RNA viral load; in 16 of 26 (62%), it was associated with CD4 count. Clearly, the field would benefit from item standardization and a priori definitions and operationalizations of adherence. We conclude that even brief self-report measures of antiretroviral adherence can be robust, and recommend items and strategies for HIV research and clinical management.
引用
收藏
页码:227 / 245
页数:19
相关论文
共 106 条
[1]   Assessment of adherence to triple antiretroviral treatment including indinavir: Role of the determination of plasma levels of indinavir [J].
Alcoba, M ;
Cuevas, TJ ;
Perez-Simon, MR ;
Mostaza, TL ;
Ortega, L ;
de Urbina, JO ;
Carro, JA ;
Raya, T ;
Abad, M ;
Martin, V .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) :253-258
[2]   Behavioral correlates of adherence to antirettoviral therapy [J].
Aloisi, MS ;
Arici, C ;
Balzano, R ;
Noto, P ;
Piscopo, R ;
Filice, G ;
Menichetti, F ;
D'Arminio Monforte, A ;
Ippolito, G ;
Girardi, E .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S145-S148
[3]  
Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
[4]   Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons [J].
Ammassari, A ;
Antinori, A ;
Aloisi, MS ;
Trotta, MP ;
Murri, R ;
Bartoli, L ;
Monforte, AD ;
Wu, AW ;
Starace, F .
PSYCHOSOMATICS, 2004, 45 (05) :394-402
[5]  
[Anonymous], 2001, AIDS and Behavior
[6]  
[Anonymous], 1979, Compliance in Health Care
[7]  
[Anonymous], 2001, AIDS and Behavior
[8]  
Antinori A, 2004, ANTIVIR THER, V9, P291
[9]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[10]   Paradoxes of adherence and drug resistance to HIV antiretroviral therapy [J].
Bangsberg, DR ;
Moss, AR ;
Deeks, SG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :696-699